Health Care

2717 posts

Buzz on the Bullboards: Pulse check on healthcare stocks

Canadian companies have made headlines from breakthrough detection tech to financing initiatives to mission-critical software enhancements.

The economics of obesity drugs: Reimbursement, pricing power, and the next healthcare cost debate

Breakthrough obesity drugs are highly effective but priced at levels that create significant affordability challenges at scale.

Gary Payton II joins multi-bagger drug technology company

Vector Science & Therapeutics (TSXV:PAIN) appoints NBA Champion Gary Payton II as Chief Athletic Ambassador for its sports medicine division.

Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA

Aurora Cannabis (TSX:ACB) earned record annual revenue and adjusted EBITDA in fiscal 2026, substantiating its shift into the medical market.

Apotex Health completes largest life sciences IPO in TSX history

Apotex Health (TSX:APTX) began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange's history.

Remote healthcare disruptor tops one million patient visits

Remote healthcare company UniDoc Health (CSE:UDOC) surpasses one million patient visits through its enterprise eHealth platform.

Healthcare micro-cap climbs after million-prescription milestone

TelyRx (TSX:TELY) recently filled its one millionth prescription, furthering its mission of expanding access to medications across the US.

MindBio unveils AI-powered fatigue detection breakthrough using voice analytics

MindBio (CSE:MBIO) developed proprietary AI that analyzes speech to detect fatigue and impairment from active substances in real time.

The mental health economy: Investing in the world’s fastest-growing invisible market

Mental health is shifting from a neglected issue to a major economic sector, driven by rising demand, workplace spending, and digital access.The mental health…

2 small-cap stocks built for the long haul

Running a fine-tooth comb through SBC Medical Group and Delta Gold Technologies, two small-cap stocks with solid long-term potential.

Meet the micro-cap biotech company reinventing regenerative medicine

An in-depth analysis of NurExone Biologic, a pre-clinical company ushering regenerative medicine into its next era of growth.

Buzz on the Bullboards: Where quarterly reports meet business outlooks

Canadian equities have experienced a volatile stretch over the past week, with both the TSX Composite...

BriaCell receives FDA green light to advance breast cancer immunotherapy

BriaCell Therapeutics (NASDAQ:BCTX) got FDA approval for clinical trials of a new off-the-shelf immunotherapy for metastatic breast cancer.